{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:55:54Z","timestamp":1775310954608,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974466"],"award-info":[{"award-number":["81974466"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Changsha, China Fundamental Research Funds for the Central Universities of Central South University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,4,13]]},"DOI":"10.1038\/s41388-023-02644-3","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T09:03:18Z","timestamp":1678179798000},"page":"1308-1320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression"],"prefix":"10.1038","volume":"42","author":[{"given":"Peijun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhikai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangfang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8568-7726","authenticated-orcid":false,"given":"Jinwu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-8350","authenticated-orcid":false,"given":"Lifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"2644_CR1","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310:1842\u201350.","journal-title":"JAMA"},{"key":"2644_CR2","first-page":"726","volume":"19","author":"AS Zhang","year":"2017","unstructured":"Zhang AS, Ostrom QT, Kruchko C, Rogers L, Peereboom DM, Barnholtz-Sloan JS. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010. Neuro Oncol. 2017;19:726\u201335.","journal-title":"Neuro Oncol"},{"key":"2644_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2017.10.017","volume":"184","author":"S Hombach-Klonisch","year":"2018","unstructured":"Hombach-Klonisch S, Mehrpour M, Shojaei S, Harlos C, Pitz M, Hamai A, et al. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response. Pharmacol Ther. 2018;184:13\u201341.","journal-title":"Pharmacol Ther"},{"key":"2644_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1227\/NEU.0000000000000486","volume":"75","author":"SL Hervey-Jumper","year":"2014","unstructured":"Hervey-Jumper SL, Berger MS. Reoperation for recurrent high-grade glioma: a current perspective of the literature. Neurosurgery. 2014;75:491\u20139. discussion 8-9","journal-title":"Neurosurgery"},{"key":"2644_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3171\/2018.4.JNS172909","volume":"131","author":"M Sharma","year":"2018","unstructured":"Sharma M, Schroeder JL, Elson P, Meola A, Barnett GH, Vogelbaum MA, et al. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery. J Neurosurg. 2018;131:489\u201399.","journal-title":"J Neurosurg"},{"key":"2644_CR6","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.7150\/ijbs.60641","volume":"17","author":"S Qin","year":"2021","unstructured":"Qin S, Mao Y, Wang H, Duan Y, Zhao L. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications. Int J Biol Sci. 2021;17:2718\u201336.","journal-title":"Int J Biol Sci"},{"key":"2644_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yexcr.2018.12.016","volume":"375","author":"B Jia","year":"2019","unstructured":"Jia B, Liu W, Gu J, Wang J, Lv W, Zhang W, et al. MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1. Exp Cell Res. 2019;375:73\u201381.","journal-title":"Exp Cell Res"},{"key":"2644_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2119\/molmed.2010.00062","volume":"17","author":"IV Ulasov","year":"2011","unstructured":"Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Mol Med. 2011;17:103\u201312.","journal-title":"Mol Med"},{"key":"2644_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11060-020-03685-4","volume":"152","author":"VP Nimbalkar","year":"2021","unstructured":"Nimbalkar VP, Kruthika BS, Sravya P, Rao S, Sugur HS, Verma BK, et al. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence. J Neurooncol. 2021;152:55\u201365.","journal-title":"J Neurooncol"},{"key":"2644_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.canlet.2018.07.018","volume":"434","author":"SF Nabavi","year":"2018","unstructured":"Nabavi SF, Atanasov AG, Khan H, Barreca D, Trombetta D, Testai L, et al. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials. Cancer Lett. 2018;434:101\u201313.","journal-title":"Cancer Lett"},{"key":"2644_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.217","volume":"4","author":"N Severe","year":"2013","unstructured":"Severe N, Dieudonne FX, Marie PJ. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death Dis. 2013;4:e463.","journal-title":"Cell Death Dis"},{"key":"2644_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10555-017-9703-z","volume":"36","author":"D Wang","year":"2017","unstructured":"Wang D, Ma L, Wang B, Liu J, Wei W. E3 ubiquitin ligases in cancer and implications for therapies. Cancer Metastasis Rev. 2017;36:683\u2013702.","journal-title":"Cancer Metastasis Rev"},{"key":"2644_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1139\/bcb-2020-0505","volume":"99","author":"C Lu","year":"2021","unstructured":"Lu C, Ning G, Si P, Zhang C, Liu W, Ge W, et al. E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4. Biochem Cell Biol. 2021;99:675\u201381.","journal-title":"Biochem Cell Biol"},{"key":"2644_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41418-020-00606-w","volume":"28","author":"J Ji","year":"2021","unstructured":"Ji J, Ding K, Luo T, Zhang X, Chen A, Zhang D, et al. TRIM22 activates NF-kappaB signaling in glioblastoma by accelerating the degradation of IkappaBalpha. Cell Death Differ. 2021;28:367\u201381.","journal-title":"Cell Death Differ"},{"key":"2644_CR15","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jfma.2020.06.004","volume":"119","author":"CM Liu","year":"2020","unstructured":"Liu CM, Yu CC, Lin T, Liao YW, Hsieh PL, Yu CH, et al. E3 ligase STUB1 attenuates stemness and tumorigenicity of oral carcinoma cells via transglutaminase 2 regulation. J Formos Med Assoc. 2020;119:1532\u20138.","journal-title":"J Formos Med Assoc"},{"key":"2644_CR16","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1038\/s41388-019-0790-x","volume":"38","author":"Z Wang","year":"2019","unstructured":"Wang Z, Kang L, Zhang H, Huang Y, Fang L, Li M, et al. AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation. Oncogene. 2019;38:5250\u201364.","journal-title":"Oncogene"},{"key":"2644_CR17","doi-asserted-by":"publisher","first-page":"12636","DOI":"10.1080\/21655979.2021.2011633","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhou M, Yang Y, Luo M. The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein. Bioengineered. 2021;12:12636\u201345.","journal-title":"Bioengineered"},{"key":"2644_CR18","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1016\/j.febslet.2011.10.038","volume":"585","author":"B Braun","year":"2011","unstructured":"Braun B, Pfirrmann T, Menssen R, Hofmann K, Scheel H, Wolf DH. Gid9, a second RING finger protein contributes to the ubiquitin ligase activity of the Gid complex required for catabolite degradation. FEBS Lett. 2011;585:3856\u201361.","journal-title":"FEBS Lett"},{"key":"2644_CR19","doi-asserted-by":"publisher","first-page":"e35528","DOI":"10.7554\/eLife.35528","volume":"7","author":"F Lampert","year":"2018","unstructured":"Lampert F, Stafa D, Goga A, Soste MV, Gilberto S, Olieric N, et al. The multi-subunit GID\/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation. Elife. 2018;7:e35528.","journal-title":"Elife"},{"key":"2644_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22749-1","volume":"12","author":"Q Wei","year":"2021","unstructured":"Wei Q, Pinho S, Dong S, Pierce H, Li H, Nakahara F, et al. MAEA is an E3 ubiquitin ligase promoting autophagy and maintenance of haematopoietic stem cells. Nat Commun. 2021;12:2522.","journal-title":"Nat Commun"},{"key":"2644_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86779-x","volume":"11","author":"MC Rittmann","year":"2021","unstructured":"Rittmann MC, Hussung S, Braun LM, Klar RFU, Biesel EA, Fichtner-Feigl S, et al. Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma. Sci Rep. 2021;11:7499.","journal-title":"Sci Rep"},{"key":"2644_CR22","doi-asserted-by":"publisher","first-page":"10373","DOI":"10.3390\/ijms221910373","volume":"22","author":"P Sledzinska","year":"2021","unstructured":"Sledzinska P, Bebyn MG, Furtak J, Kowalewski J, Lewandowska MA. Prognostic and Predictive Biomarkers in Gliomas. Int J Mol Sci. 2021;22:10373.","journal-title":"Int J Mol Sci"},{"key":"2644_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.canlet.2015.06.023","volume":"379","author":"YJ Chen","year":"2016","unstructured":"Chen YJ, Wu H, Shen XZ. The ubiquitin-proteasome system and its potential application in hepatocellular carcinoma therapy. Cancer Lett. 2016;379:245\u201352.","journal-title":"Cancer Lett"},{"key":"2644_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.06.001","volume":"117","author":"K Nakayama","year":"2004","unstructured":"Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell. 2004;117:941\u201352.","journal-title":"Cell"},{"key":"2644_CR25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00432-012-1237-8","volume":"138","author":"C Sun","year":"2012","unstructured":"Sun C, Song H, Zhang H, Hou C, Zhai T, Huang L, et al. CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1alpha (HIF-1alpha). J Cancer Res Clin Oncol. 2012;138:1619\u201324.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2644_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.canlet.2016.05.014","volume":"378","author":"FB Lai","year":"2016","unstructured":"Lai FB, Liu WT, Jing YY, Yu GF, Han ZP, Yang X, et al. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-kappaB\/HIF-1alpha pathway. Cancer Lett. 2016;378:131\u201341.","journal-title":"Cancer Lett"},{"key":"2644_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/ijms23010297","volume":"23","author":"Q Wu","year":"2021","unstructured":"Wu Q, Berglund AE, MacAulay RJ, Etame AB. A novel role of BIRC3 in stemness reprogramming of glioblastoma. Int J Mol Sci. 2021;23:297.","journal-title":"Int J Mol Sci"},{"key":"2644_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12195-021-00691-y","volume":"14","author":"PS Nakod","year":"2021","unstructured":"Nakod PS, Kim Y, Rao SS. The impact of astrocytes and endothelial cells on glioblastoma stemness marker expression in multicellular spheroids. Cell Mol Bioeng. 2021;14:639\u201351.","journal-title":"Cell Mol Bioeng"},{"key":"2644_CR29","doi-asserted-by":"publisher","first-page":"e0137703","DOI":"10.1371\/journal.pone.0137703","volume":"10","author":"Y Lee","year":"2015","unstructured":"Lee Y, Kim KH, Kim DG, Cho HJ, Kim Y, Rheey J, et al. FoxM1 promotes stemness and radio-resistance of glioblastoma by regulating the master stem cell regulator Sox2. PLoS One. 2015;10:e0137703.","journal-title":"PLoS One"},{"key":"2644_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/1878-0261.12034","volume":"11","author":"C Zhang","year":"2017","unstructured":"Zhang C, Mukherjee S, Tucker-Burden C, Ross JL, Chau MJ, Kong J, et al. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Mol Oncol. 2017;11:280\u201394.","journal-title":"Mol Oncol"},{"key":"2644_CR31","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1158\/0008-5472.CAN-17-1346","volume":"78","author":"H Dopeso","year":"2018","unstructured":"Dopeso H, Jiao HK, Cuesta AM, Henze AT, Jurida L, Kracht M, et al. PHD3 controls lung cancer metastasis and resistance to EGFR inhibitors through TGFalpha. Cancer Res. 2018;78:1805\u201319.","journal-title":"Cancer Res"},{"key":"2644_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6582","volume":"5","author":"AT Henze","year":"2014","unstructured":"Henze AT, Garvalov BK, Seidel S, Cuesta AM, Ritter M, Filatova A, et al. Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR. Nat Commun. 2014;5:5582.","journal-title":"Nat Commun"},{"key":"2644_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2020.10.011","volume":"496","author":"M Shi","year":"2021","unstructured":"Shi M, Dai WQ, Jia RR, Zhang QH, Wei J, Wang YG, et al. APC(CDC20)-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma. Cancer Lett. 2021;496:144\u201355.","journal-title":"Cancer Lett"},{"key":"2644_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3109\/15376516.2012.673088","volume":"22","author":"S Sen Banerjee","year":"2012","unstructured":"Sen Banerjee S, Thirunavukkarasu M, Tipu Rishi M, Sanchez JA, Maulik N, Maulik G. HIF-prolyl hydroxylases and cardiovascular diseases. Toxicol Mech Methods. 2012;22:347\u201358.","journal-title":"Toxicol Mech Methods"},{"key":"2644_CR35","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1128\/MCB.25.15.6415-6426.2005","volume":"25","author":"DA Chan","year":"2005","unstructured":"Chan DA, Sutphin PD, Yen SE, Giaccia AJ. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol Cell Biol. 2005;25:6415\u201326.","journal-title":"Mol Cell Biol"},{"key":"2644_CR36","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1038\/s41388-020-01425-6","volume":"39","author":"X Xia","year":"2020","unstructured":"Xia X, Wang S, Ni B, Xing S, Cao H, Zhang Z, et al. Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p\/PHD3\/HIF-1alpha positive feedback loop. Oncogene. 2020;39:6231\u201344.","journal-title":"Oncogene"},{"key":"2644_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00535-014-1030-3","volume":"50","author":"T Tanaka","year":"2015","unstructured":"Tanaka T, Li TS, Urata Y, Goto S, Ono Y, Kawakatsu M, et al. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma. J Gastroenterol. 2015;50:975\u201383.","journal-title":"J Gastroenterol"},{"key":"2644_CR38","doi-asserted-by":"publisher","first-page":"e66255","DOI":"10.1371\/journal.pone.0066255","volume":"8","author":"S Ohnishi","year":"2013","unstructured":"Ohnishi S, Maehara O, Nakagawa K, Kameya A, Otaki K, Fujita H, et al. Hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors. PLoS One. 2013;8:e66255.","journal-title":"PLoS One"},{"key":"2644_CR39","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1038\/s41388-022-02397-5","volume":"41","author":"H Xu","year":"2022","unstructured":"Xu H, Jin J, Chen Y, Wu G, Zhu H, Wang Q, et al. GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. Oncogene. 2022;41:3876\u201385.","journal-title":"Oncogene"},{"key":"2644_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.canlet.2020.03.004","volume":"478","author":"X Wu","year":"2020","unstructured":"Wu X, Zhou Z, Xu S, Liao C, Chen X, Li B, et al. Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling. Cancer Lett. 2020;478:93\u2013106.","journal-title":"Cancer Lett"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02644-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T05:04:59Z","timestamp":1681362299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02644-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":40,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,4,13]]}},"alternative-id":["2644"],"URL":"https:\/\/doi.org\/10.1038\/s41388-023-02644-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2123722\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"assertion":[{"value":"1 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental protocol was approved by the Ethics Committee of Xiangya Hospital of Central South University. Animals were raised and operated in accordance with the guidelines formulated by the Medical Research Animal Ethics Committee of Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}